R&D; Blueprint

Coronavirus disease (COVID-2019) R&D;

On 31 December 2019, WHO was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China. The coronavirus disease (COVID-2019) was identified as the causative virus by Chinese authorities on 7 January. As part of WHO’s response to the outbreak, the R&D; Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus.

COVID-19 Public Health Emergency of International Concern (PHEIC)

Global research and innovation forum: towards a research roadmap

On 30 January 2020, following the recommendations of the Emergency Committee, the WHO Director-General declared that the outbreak constitutes a Public Health Emergency of International Concern (PHEIC).

World scientists on COVID-19 met at the World Health Organization’s Geneva headquarters from 11 to 12 February 2020 to assess the current level of knowledge about the new virus, agree on critical research questions that need to be answered urgently, and ways to work together to accelerate and fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks.

Latest reports

Vaccines

Animal Models

Therapeutics

Ethics

Diagnostics

Scientific Advisory Group

Global Coordination Mechanism

R&D; key actions by diseases